Akouos Inc - ESG Rating & Company Profile powered by AI
Full Sustainability analysis of Akouos Inc can be accessed by signing up for free. This ESG rating covers seventeen United Nations Sustainable Development Goals including: 'Clean Water & Sanitation', 'Climate Action' and 'Life on Land'. Scroll down to the bottom of the webpage for potential risks for Akouos Inc based on sector, location and size.
Akouos Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.5; made up of an environmental score of 4.0, social score of 1.6 and governance score of 4.8.
3.5
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1144 | Veerhealth Care Ltd | 3.6 | Medium |
| 1144 | iStreet Network Ltd | 3.6 | Medium |
| 1186 | Akouos Inc | 3.5 | Medium |
| 1186 | CRISPR Therapeutics AG | 3.5 | Medium |
| 1186 | Catalent Inc | 3.5 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Akouos Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Akouos Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Akouos Inc report the average age of the workforce?
Sign up for free to unlockDoes Akouos Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Akouos Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Akouos Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Akouos Inc offer flexible work?
Sign up for free to unlockDoes Akouos Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Akouos Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Akouos Inc conduct supply chain audits?
Sign up for free to unlockDoes Akouos Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Akouos Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Akouos Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Akouos Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Akouos Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Akouos Inc disclose water use targets?
Sign up for free to unlockDoes Akouos Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Akouos Inc have a product recall in the last two years?
Sign up for free to unlockDoes Akouos Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Akouos Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Akouos Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Akouos Inc disclose parental leave metrics?
Sign up for free to unlockDoes Akouos Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Akouos Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Akouos Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Akouos Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Akouos Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Akouos Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Akouos Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Akouos Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Akouos Inc disclose its waste policy?
Sign up for free to unlockDoes Akouos Inc report according to TCFD requirements?
Sign up for free to unlockDoes Akouos Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Akouos Inc disclose energy use targets?
Sign up for free to unlockDoes Akouos Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Akouos Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Akouos Inc
These potential risks are based on the size, segment and geographies of the company.
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma. In addition, its precision genetic medicine platform addresses hearing loss related to genes needed for supporting cell function. Akouos, Inc. was incorporated in 2016 and is based in Boston, Massachusetts.